Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1986; Volume 29,Issue 1
  • You have access
    Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel
    Molecular Pharmacology January 1986, 29 (1) 1-6;
  • You have access
    Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
    L C Mahan and P A Insel
    Molecular Pharmacology January 1986, 29 (1) 7-15;
  • You have access
    Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
    L C Mahan and P A Insel
    Molecular Pharmacology January 1986, 29 (1) 16-22;
  • You have access
    Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    M Laburthe, A Couvineau and C Rouyer-Fessard
    Molecular Pharmacology January 1986, 29 (1) 23-27;
  • You have access
    Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.
    H Weinstein, A P Mazurek, R Osman and S Topiol
    Molecular Pharmacology January 1986, 29 (1) 28-33;
  • You have access
    Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
    Molecular Pharmacology January 1986, 29 (1) 34-38;
  • You have access
    Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
    R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
    Molecular Pharmacology January 1986, 29 (1) 39-44;
  • You have access
    Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices.
    R S Jope and G V Johnson
    Molecular Pharmacology January 1986, 29 (1) 45-51;
  • You have access
    The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
    F Henderson, C Prior, J Dempster and I G Marshall
    Molecular Pharmacology January 1986, 29 (1) 52-64;
  • You have access
    Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
    P M Matthews, D Foxall, L Shen and T E Mansour
    Molecular Pharmacology January 1986, 29 (1) 65-73;
  • You have access
    The interaction of the beta-anomer of doxorubicin with B and Z DNA.
    M Britt, F Zunino and J B Chaires
    Molecular Pharmacology January 1986, 29 (1) 74-80;
  • You have access
    Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
    T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
    Molecular Pharmacology January 1986, 29 (1) 81-87;
  • You have access
    A new method to study glutathione adduct formation in periportal and pericentral regions of the liver lobule by micro-reflectance spectrophotometry.
    C Harris and R G Thurman
    Molecular Pharmacology January 1986, 29 (1) 88-96;
  • You have access
    Cysteine conjugate beta-lyase in the gastrointestinal bacterium Eubacterium limosum.
    G L Larsen and J L Stevens
    Molecular Pharmacology January 1986, 29 (1) 97-103;
  • You have access
    Regulation of protein synthesis in isolated hepatocytes by calcium-mobilizing hormones.
    C O Brostrom, S B Bocckino, M A Brostrom and E M Galuska
    Molecular Pharmacology January 1986, 29 (1) 104-111;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 29, Issue 1
1 Jan 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics